Presentation is loading. Please wait.

Presentation is loading. Please wait.

Presence of anti-HPV E6/E7 epitope CD8+ T-cell responses in HPV+ OPSCC tumors. Presence of anti-HPV E6/E7 epitope CD8+ T-cell responses in HPV+ OPSCC tumors.

Published byEvelyn Allen Modified over 5 years ago

Similar presentations

Presentation on theme: "Presence of anti-HPV E6/E7 epitope CD8+ T-cell responses in HPV+ OPSCC tumors. Presence of anti-HPV E6/E7 epitope CD8+ T-cell responses in HPV+ OPSCC tumors."— Presentation transcript:

1 Presence of anti-HPV E6/E7 epitope CD8+ T-cell responses in HPV+ OPSCC tumors.
Presence of anti-HPV E6/E7 epitope CD8+ T-cell responses in HPV+ OPSCC tumors. Tumors from HPV+ patients with OPSCC were assessed for the presence of CD8+ T-cell responses to the HLA-A*0201-restricted HPV E6/E7 epitopes, LLMGTLGIV (LV9), TIHDIILECV (TV10), and KLPQLCTEL (KL9) using dextramers. A, A representative dot plot showing the presence of all 3 reactivities in a tumor. B, Quantification of responses to all three epitopes (LV9, TV10, and KL9) from 5 HPV+ OPSCC tumors. Emma Reeves et al. Cancer Immunol Res 2019;7: ©2019 by American Association for Cancer Research

Download ppt "Presence of anti-HPV E6/E7 epitope CD8+ T-cell responses in HPV+ OPSCC tumors. Presence of anti-HPV E6/E7 epitope CD8+ T-cell responses in HPV+ OPSCC tumors."

Similar presentations

Anti–4-1BB/PD-1 combination enriched CD8+ T cells in TILs

Anti–4-1BB/PD-1 combination enriched CD8+ T cells in TILs
Frequencies of immune cell types show much stronger variations between tumor types in the tumor infiltrate compared with the spleen and tumor-draining.

Frequencies of immune cell types show much stronger variations between tumor types in the tumor infiltrate compared with the spleen and tumor-draining.
FIP200 loss links to poor autophagy and high apoptosis in naïve T cells in tumor. FIP200 loss links to poor autophagy and high apoptosis in naïve T cells.

FIP200 loss links to poor autophagy and high apoptosis in naïve T cells in tumor. FIP200 loss links to poor autophagy and high apoptosis in naïve T cells.
Treatment of human MCC tumors with intralesional IFNβ is associated with MHC-I upregulation. Treatment of human MCC tumors with intralesional IFNβ is associated.

Treatment of human MCC tumors with intralesional IFNβ is associated with MHC-I upregulation. Treatment of human MCC tumors with intralesional IFNβ is associated.
Anti–4-1BB/PD-1 combination enhanced antigen-specific T-cell response.

Anti–4-1BB/PD-1 combination enhanced antigen-specific T-cell response.
B7-H4 expression correlates with MHC-I expression and improved prognosis in patients with breast cancer. B7-H4 expression correlates with MHC-I expression.

B7-H4 expression correlates with MHC-I expression and improved prognosis in patients with breast cancer. B7-H4 expression correlates with MHC-I expression.
Kinetic changes of sPD-L1 and cytokines, and kinetic radiographic reduction in tumor size after ipilimumab plus bevacizumab treatment. Kinetic changes.

Kinetic changes of sPD-L1 and cytokines, and kinetic radiographic reduction in tumor size after ipilimumab plus bevacizumab treatment. Kinetic changes.
The absence of ADCC by nivolumab in vitro.

The absence of ADCC by nivolumab in vitro.
Tregs and APC subsets in TDLNs of patients with cervical cancer.

Tregs and APC subsets in TDLNs of patients with cervical cancer.
Tetramer staining performed to determine frequencies of epitope-specific T cells after clearance of HPV16 infection but prior to isolation of T-cell clones.

Tetramer staining performed to determine frequencies of epitope-specific T cells after clearance of HPV16 infection but prior to isolation of T-cell clones.
FIP200 loss links to poor autophagy and high apoptosis in naïve T cells in tumor. FIP200 loss links to poor autophagy and high apoptosis in naïve T cells.

FIP200 loss links to poor autophagy and high apoptosis in naïve T cells in tumor. FIP200 loss links to poor autophagy and high apoptosis in naïve T cells.
Quantification of MHC-I, β2m, and T-cell subsets.

Quantification of MHC-I, β2m, and T-cell subsets.
CPI-444 efficacy requires CD8+ T cells and is associated with increased CD73 expression. CPI-444 efficacy requires CD8+ T cells and is associated with.

CPI-444 efficacy requires CD8+ T cells and is associated with increased CD73 expression. CPI-444 efficacy requires CD8+ T cells and is associated with.
Exosome-mediated inhibition of T cells is reversible.

Exosome-mediated inhibition of T cells is reversible.
Frequency and kinetics of killer cell apoptosis are dependent on functional conjugations with multiple NALM-6 tumor cells. Frequency and kinetics of killer.

Frequency and kinetics of killer cell apoptosis are dependent on functional conjugations with multiple NALM-6 tumor cells. Frequency and kinetics of killer.
ERAP1 allotype combinations from CD8/TILlow tumors have reduced trimming activity. ERAP1 allotype combinations from CD8/TILlow tumors have reduced trimming.

ERAP1 allotype combinations from CD8/TILlow tumors have reduced trimming activity. ERAP1 allotype combinations from CD8/TILlow tumors have reduced trimming.
Generation of HPV E782-90 from natural precursors is impaired in CD8/TILlow ERAP1 allotype combinations. Generation of HPV E782-90 from natural precursors.

Generation of HPV E from natural precursors is impaired in CD8/TILlow ERAP1 allotype combinations. Generation of HPV E from natural precursors.
Characteristics of spontaneous HPV buccal tumors.

Characteristics of spontaneous HPV buccal tumors.
Antigen specificity of direct tumor recognition by HTLV-1 Tax–reactive HTLs. The peptide Tax191-205-reactive HTLs 5G, 8E, and 9B (A-C) and peptide Tax305-319-reactive.

Antigen specificity of direct tumor recognition by HTLV-1 Tax–reactive HTLs. The peptide Tax reactive HTLs 5G, 8E, and 9B (A-C) and peptide Tax reactive.
Interacting MDSCs and mast cells (MC) in human colon carcinoma and in the colon of AOM/DSS-induced tumor-bearing mice. Interacting MDSCs and mast cells.

Interacting MDSCs and mast cells (MC) in human colon carcinoma and in the colon of AOM/DSS-induced tumor-bearing mice. Interacting MDSCs and mast cells.

Similar presentations

Ads by Google